Effects of a hydroxyl radical scavenger on delayed ischemic neurological deficits following aneurysmal subarachnoid hemorrhage: Results of a multicenter, placebo-controlled double-blind trial

Journal of Neurosurgery

Volumn 84, Issue 5, 1996, Pages 792-803

  Asano, Takao ^a   Takakura, Kintomo ^b   Sano, Keiji ^b   Kikuchi, Haruhiko ^b   Nagai, Hajime ^b   Saito, Isamu ^b   Tamura, Akira ^b   Ochiai, Chikayuki ^b   Sasaki, Tomio ^b  

^a SAITAMA MEDICAL UNIVERSITY   (Japan)

^b NONE

Author keywords

Free radical; Free radical scavenger; Hydroxyl radical; Nicaraven; Subarachnoid hemorrhage; Vasospasm

Indexed keywords

HYDROXYL RADICAL; NICARAVEN; SCAVENGER;

ADULT; AGED; ARTICLE; BRAIN ANGIOGRAPHY; BRAIN ARTERY ANEURYSM; BRAIN ISCHEMIA; BRAIN VASOSPASM; CLINICAL ARTICLE; CLINICAL PROTOCOL; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; CONSCIOUSNESS DISORDER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; FEMALE; HUMAN; INJURY SCALE; INTRAVENOUS DRUG ADMINISTRATION; MALE; MULTICENTER STUDY; PHASE 3 CLINICAL TRIAL; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SUBARACHNOID HEMORRHAGE; TREATMENT OUTCOME;

ADULT; AGED; DOUBLE-BLIND METHOD; FEMALE; FREE RADICAL SCAVENGERS; HUMANS; HYDROXYL RADICAL; INTRACRANIAL ANEURYSM; MALE; MIDDLE AGED; NIACINAMIDE; SUBARACHNOID HEMORRHAGE; TIME FACTORS; TREATMENT OUTCOME;

EID: 0029874741     PISSN: 00223085     EISSN: None     Source Type: Journal    
DOI: 10.3171/jns.1996.84.5.0792     Document Type: Article

References (76)

1. Allen GS, Ahn HS, Preziosi TJ, et al: Cerebral arterial spasm - a controlled trial of nimodipine in patients with subarachnoid hemorrhage. New Engl J Med 308:619-624, 1983
2. Asano T, Johshita H, Koide T, et al: Amelioration of ischaemic cerebral oedema by a free radical scavenger, AVS: 1,2-bis (nicotinamide)-propane. An experimental study using a regional ischaemia model in cats. Neurol Res 6:163-168, 1984
3. Asano T, Koide T, Gotoh O, et al: The role of free radicals and eicosanoids in the pathogenetic mechanism underlying ischemic brain edema. Mol Chem Neuropathol 10:101-133, 1989
4. Asano T, Matsui T: Cerebral vasospasm: a disorder of the local mechanotransduction system in cerebral arteries. Crit Rev Neurosurg 3:284-294, 1993
5. Asano T, Matsui T: Current controversies concerning the pathogenetic mechanism underlying cerebral vasospasm. Crit Rev Neurosurg 3:369-379, 1994
6. Asano T, Matsui T, Shigeno T, et al: [Cerebral vasospasm and free radicals. A disorder of mechanotransduction.] Brain Nerve 45:825-838, 1993 (Jpn)
7. Asano T, Matsui T, Takuwa Y: Lipid peroxidation, protein kinase C, and cerebral vasospasm. Crit Rev Neurosurg 1: 361-379, 1991
8. Asano T, Sasaki T, Koide T, et al: Experimental evaluation of the beneficial effect of an antioxidant on cerebral vasospasm. Neurol Res 6:49-53, 1984
9. Asano T, Takakura K, Sano K, et al: [The utility of nicaraven for the delayed ischemic neurological deficits following SAH due to aneurysmal rupture: results of a multicenter, controlled double-blind trial.] Rinsho To Kenkyu 66:234-250 (Jpn)
10. Asano T, Tanishima T, Sasaki T, et al: Possible participation of free radical reactions initiated by clot lysis in the pathogenesis of vasospasm after subarachnoid hemorrhage, in Wilkins RH (ed): Cerebral Arterial Spasm. Baltimore: Williams & Wilkins, 1980, pp 190-201
11. Barber AA, Bernheim F: Lipid peroxidation: its measurement, occurrence, and significance in animal tissues. Adv Geront Res 2:355-403, 1967
12. Beckman JS: The double-edged role of nitric oxide in brain function and superoxide-mediated injury. J Dev Physiol 15: 53-59, 1991
13. Brownlee NR, Huttner JJ, Panganamala RV, et al: Role of vitamin E in glutathione-induced oxidant stress: methemoglobin, lipid peroxidation, and hemolysis. J Lipid Res 18:635-644, 1977
14. Carrell RW, Winterbourn CC, Rachmilewitz EA: Activated oxygen and haemolysis. Br J Haematol 30:259-264, 1975
15. Comair YG, Schipper HM, Brem S: The prevention of oxyhemoglobin-induced endothelial and smooth muscle cytoskeletal injury by deferoxamine. Neurosurgery 32:58-65, 1993
16. Echlin F: Experimental vasospasm, acute and chronic, due to blood in the subarachnoid space. J Neurosurg 35:646-656, 1971
17. Espinosa F, Weir B, Overton T, et al: A randomized placebo-controlled double-blind trial of nimodipine after SAH in monkeys. Part 1: Clinical and radiological findings. J Neurosurg 60:1167-1175, 1984
18. Fadel MM, Foley PL, Kassell NF, et al: Effect of histidine, a free radical scavenger, on subarachnoid hemorrhage-induced vasospasm in the rabbit. Can J Neurol Sci 20 (Suppl 1):S13, 1993 (Abstract)
19. Findlay JM, Weir BKA, Kassell NF, et al: Intracisternal recombinant tissue plasminogen activator after aneurysmal subarachnoid hemorrhage. J Neurosurg 75:181-188, 1991
20. Finn SS, Stephensen SA, Miller CA, et al: Observations on the perioperative management of aneurysmal subarachnoid hemorrhage. J Neurosurg 65:48-62, 1986
21. Fisher CM, Kistler JP, Davis JM: Relation of cerebral vasospasm to subarachnoid hemorrhage visualized by computerized tomographic scanning. Neurosurgery 6:1-9, 1980
22. Grotenhuis JA, Bettag W, Fiebach BJO, et al: Intracarotid slow bolus injection of nimodipine during angiography for treatment of cerebral vasospasm after SAH. A preliminary report. J Neurosurg 61:231-240, 1984
23. Gutteridge JMC: Iron promoters of the Fenton reaction and lipid peroxidation can be released from haemoglobin by peroxides. FEBS Lett 201:291-295, 1986
24. Haley EC Jr, Kassell NF, Torner JC, et al: A randomized trial of two doses of nicardipine in aneurysmal subarachnoid hemorrhage. A report of the Cooperative Aneurysm Study. J Neurosurg 80:788-796, 1994
25. Halliwell B, Gutteridge MC: Free Radicals in Biology and Medicine. New York: Oxford University Press, 1985
26. Hunt WE, Hess RM: Surgical risk as related to time of intervention in the repair of intracranial aneurysms. J Neurosurg 28:14-20, 1968
27. Jennett B, Bond M: Assessment of outcome after severe brain damage A practical scale. Lancet 1:480-484, 1975
28. Kanamaru K, Weir BKA, Simpson I, et al: Effect of 21-aminosteroid U-74006F on lipid peroxidation in subarachnoid clot. J Neurosurg 74:454-459, 1991
29. Kassell NF, Peerless SJ, Durward QJ, et al: Treatment of ischemic deficits from vasospasm with intravascular volume expansion and induced arterial hypertension. Neurosurgery 11:337-343, 1982
30. Kassell NF, Sasaki T, Colohan ART, et al: Cerebral vasospasm following aneurysmal subarachnoid hemorrhage. Stroke 16: 562-572, 1985
31. Kassell NF, Tomer JC, Haley EC Jr, et al: The International Cooperative Study on the Timing of Aneurysm Surgery. Part 1: Overall management results. J Neurosurg 73:18-36, 1990
32. Kellogg EW III, Fridovich I: Liposome oxidation and erythrocyte lysis by enzymatically generated superoxide and hydrogen peroxide. J Biol Chem 252:6721-6728, 1977
33. Kindt GW, McGillicuddy J, Pritz M, et al: Hypertension and hypervolemia as therapy for patients with vasospasm, in Wilkins RH (ed): Cerebral Arterial Spasm. Baltimore: Williams & Wilkins, 1980, pp 659-664
34. Kodama N, Sasaki T, Yamanobe K, et al: Prevention of vasospasm: cisternal irrigation therapy with urokinase and ascorbic acid, in Wilkins RH (ed): Cerebral Arterial Spasm. New York: Raven Press, 1988, pp 415-429
35. Koide T, Neichi T, Takato M, et al: Possible mechanisms of 15-hydroperoxyarachidonic acid-induced contraction of the canine basilar artery in vitro. J Pharmacol Exp Ther 221:481-488, 1982
36. Koide T, Noda Y, Hata S, et al: Contraction of the canine basilar artery following linoleic, arachidonic, 13-hydroperoxylinoleic or 15-hydroperoxyarachidonic acid. Proc Soc Exp Biol Med 168:399-402, 1981
37. Macdonald RL, Weir BKA: A review of hemoglobin and the pathogenesis of cerebral vasospasm. Stroke 22:971-982, 1991
38. Macdonald RL, Weir BKA, Runzer TD, et al: Etiology of cerebral vasospasm in primates. J Neurosurg 75:415-424, 1991
39. Matsui T, Asano T: Effects of new 21-aminosteroid Tirilazad Mesylate (U74006F) on chronic cerebral vasospasm in a "two-hemorrhage" model of beagle dogs. Neurosurgery 34: 1035-1039, 1994
40. Matsui T, Kaizu H, Itoh S, et al: The role of active smooth-muscle contraction in the occurrence of chronic vasospasm in the canine two-hemorrhage model. J Neurosurg 80:276-282, 1994
41. Matsui T, Sugawa M, Johshita H, et al: Activation of the protein kinase-C mediated contractile system in the canine basilar artery undergoing chronic vasospasm. Stroke 22:1183-1187, 1991
42. Matsui T, Takuwa Y, Johshita H, et al: Possible role of protein kinase C-dependent smooth muscle contraction in the pathogenesis of chronic cerebral vasospasm. J Cereb Blood Flow Metab 11:143-149, 1990
43. Matsui T, Takuwa Y, Johshita H, et al: Possible role of protein kinase C-dependent smooth muscle contraction in the pathogenesis of chronic cerebral vasospasm. J Cereb Blood Flow Metab 12:707, 1992 (Erratum)
44. Mayberg MR, Okada T, Bark DH: The role of hemoglobin in arterial narrowing after subarachnoid hemorrhage. J Neurosurg 72:634-640, 1990
45. Misra HP, Fridovich I: The generation of superoxide radical during the autoxidation of hemoglobin. J Biol Chem 247: 6960-6962, 1972
46. Mori T, Nagata K, Matsui T, et al: Superoxide anions in the pathogenesis of talc-induced cerebral vasocontraction. Neuropathol Appl Neurobiol 21:378-385, 1995
47. Nosko M, Weir B, Krueger C, et al: Nimodipine and chronic vasospasm in monkeys: Part 1. Clinical and radiological findings. Neurosurgery 16:129-140, 1985
48. Nozaki K, Okamoto S, Yamamoto H, et al: Red blood cells are essential for late vasospasm following experimentally induced subarachnoid hemorrhage in dogs. Neurol Med Chir 30: 10-15, 1990
49. Ochiai C, Asano T, Inoh S, et al: [Early Phase II clinical study of nicaraven - a free radical scavenger - in patients after ruptured cerebral aneurysms.] Kiso To Rinsho 23:251-261, 1989 (Jpn)
50. Ohta T, Kikuchi H, Hashi K, et al: Nizofenone administration in the acute stage following subarachnoid hemorrhage. Results of a multi-center controlled double-blind clinical study. J Neurosurg 64:420-426, 1986
51. Ohta S, Nishihara J, Kohno K, et al: A relation between free radical reaction and PKC-dependent smooth muscle contraction in the pathogenesis of cerebral vasospasm, in Asano T (ed): Vasospasm Grand Round. CVD Grand Round Series. Tokyo: Neuron-Sha, 1994, Vol 1, pp 43-51
52. Peterson JW, Roussos L, Kwun BD, et al: Evidence of the role of hemolysis in experimental cerebral vasospasm. J Neurosurg 72:775-781, 1990
53. Petruk KC, West M, Mohr G, et al: Nimodipine treatment in poor-grade aneurysm patients. Results of a multicenter double-blind placebo-controlled trial. J Neurosurg 68:505-517, 1988
54. Pickard JD, Murray GD, Illingworth R, et al: Effect of oral nimodipine on cerebral infarction and outcome after subarachnoid haemorrhage: British aneurysm nimodipine trial. Br Med J 298:636-642, 1989
55. Sakaki S. Kuwabara H, Ohta S: Biological defence mechanism in the pathogenesis of prolonged cerebral vasospasm in the patients with ruptured intracranial aneurysms. Stroke 17: 196-202, 1986
56. Sakaki S, Ohta S, Nakamura H, et al: Free radical reaction and biological defense mechanism in the pathogenesis of prolonged vasospasm in experimental subarachnoid hemorrhage. J Cereb Blood Flow Metab 8:1-8, 1988
57. Sako M, Nishihara J, Ohta S, et al: Role of protein kinase C in the pathogenesis of cerebral vasospasm after subarachnoid hemorrhage. J Cereb Blood Flow Metab 13:247-254, 1993
58. Sasaki T, Ohta T, Kikuchi H, et al: Early Phase II clinical trial of rtPA (TD-2061) against cerebral vasospasm following aneurysmal subarachnoid hemorrhage, in Findlay JM (ed): Cerebral Vasospasm. Amsterdam: Elsevier, 1993, pp 463-466
59. Sasaki T, Wakai S, Asano T, et al: The effect of a lipid hydroperoxide of arachidonic acid on the canine basilar artery. An experimental study on cerebral vasospasm. J Neurosurg 54: 357-365, 1981
60. Shibuya M, Suzuki Y, Sugita K, et al: Effect of AT877 on cerebral vasospasm after aneurysmal subarachnoid hemorrhage. Results of a prospective placebo-controlled double-blind trial. J Neurosurg 76:571-577, 1992
61. Shimizu T, Watanabe T, Asano T, et al: Activation of the arachidonate 5-lipoxygenase pathway in the canine basilar artery after experimental subarachnoid hemorrhage. J Neurochem 51:1126-1131, 1988
62. Siesjö BK: Pathophysiology and treatment of focal cerebral ischemia. Part I. Pathophysiology. J Neurosurg 77:169-184, 1992
63. Siesjö BK: Pathophysiology and treatment of focal cerebral ischemia. Part II. Mechanisms of damage and treatment. J Neurosurg 77:337-354, 1992
64. Steele JA, Stockbridge N, Maljkovic G, et al: Free radicals mediate actions of oxyhemoglobin on cerebrovascular smooth muscle cells. Circ Res 68:416-423, 1991
65. Takuwa Y, Matsui T, Abe Y, et al: Alterations in protein kinase C activity and membrane lipid metabolism in cerebral vasospasm after subarachnoid hemorrhage. J Cereb Blood Flow Metab 13:409-415, 1993
66. Tanishima T: Cerebral vasospasm: contractile activity of hemoglobin in isolated canine basilar arteries. J Neurosurg 53: 787-793, 1980
67. Teasdale G, Jennett B: Assessment of coma and impaired consciousness. A practical scale. Lancet 2:81-84, 1974
68. Traystman RJ, Kirsch JR, Koehler RC: Oxygen radical mechanisms of brain injury following ischemia and reperfusion. J Appl Physiol 71:1185-1195, 1991
69. Varsos VG, Liszczak TM, Han DH, et al: Delayed cerebral vasospasm is not reversible by aminophylline, nifedipine, or papaverine in a "two-hemorrhage" canine model. J Neurosurg 58:11-17, 1983
70. Vollmer DG, Hongo K, Ogawa H, et al: A study of the effectiveness of the iron-chelating agent deferoxamine as vasospasm prophylaxis in a rabbit model of subarachnoid hemorrhage. Neurosurgery 28:27-32, 1991
71. Vollmer DG, Kassell NF, Hongo K, et al: Effect of the nonglucocorticoid 21-aminosteroid U74006F on experimental cerebral vasospasm. Surg Neurol 31:190-194, 1989
72. Watanabe T, Asano T, Shimizu T, et al: Participation of lipoxygenase products from arachidonic acid in the pathogenesis of cerebral vasospasm. J Neurochem 50:1145-1150, 1988
73. Watanabe T, Nishiyama M, Okamoto H, et al: Effects of ebselen (PZ-51) on experimental cerebral vasospasm, in Wendel A (ed): Selenium in Biology and Medicine. Berlin: Springer-Verlag, 1989, pp 177-184
74. Watanabe T, Sasaki T, Asano T, et al: Changes of glutathione peroxidase and lipid peroxides in the cerebrospinal fluid and serum after subarachnoid hemorrhage - with special reference to the occurrence of cerebral vasospasm. Neurol Med Chir 28:645-649, 1988
75. Winterbourn CC, McGrath BM, Carrell RW: Reactions involving superoxide and normal and unstable haemoglobins. Biochem J 155:493-502, 1976
76. Yoshida S, Inoh S, Asano T, et al: Effect of transient ischemia on free fatty acids and phospholipids in the gerbil brain. Lipid peroxidation as possible cause of postischemic injury. J Neurosurg 53:323-331, 1980